IHH Healthcare Berhad, an investment holding company, provides healthcare services. More Details
No risks detected for IHH from our risk checks.
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IHH is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: IHH's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: IHH underperformed the MY Healthcare industry which returned -6.3% over the past year.
Return vs Market: IHH underperformed the MY Market which returned 2.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StCalculating The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)
1 month ago | Simply Wall StIHH Healthcare Berhad (KLSE:IHH) Takes On Some Risk With Its Use Of Debt
1 month ago | Simply Wall StIHH Healthcare Berhad Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IHH (MYR5.2) is trading below our estimate of fair value (MYR5.38)
Significantly Below Fair Value: IHH is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: IHH is unprofitable, so we can't compare its PE Ratio to the MY Healthcare industry average.
PE vs Market: IHH is unprofitable, so we can't compare its PE Ratio to the MY market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IHH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IHH is good value based on its PB Ratio (2x) compared to the MY Healthcare industry average (2.9x).
How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IHH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.7%).
Earnings vs Market: IHH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IHH's is expected to become profitable in the next 3 years.
Revenue vs Market: IHH's revenue (12.7% per year) is forecast to grow faster than the MY market (7.1% per year).
High Growth Revenue: IHH's revenue (12.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IHH's Return on Equity is forecast to be low in 3 years time (4.9%).
How has IHH Healthcare Berhad performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IHH is currently unprofitable.
Growing Profit Margin: IHH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IHH is unprofitable, and losses have increased over the past 5 years at a rate of 29.7% per year.
Accelerating Growth: Unable to compare IHH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IHH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-12.6%).
Return on Equity
High ROE: IHH has a negative Return on Equity (-0.94%), as it is currently unprofitable.
How is IHH Healthcare Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: IHH's short term assets (MYR7.2B) exceed its short term liabilities (MYR6.0B).
Long Term Liabilities: IHH's short term assets (MYR7.2B) do not cover its long term liabilities (MYR11.6B).
Debt to Equity History and Analysis
Debt Level: IHH's debt to equity ratio (36.6%) is considered satisfactory.
Reducing Debt: IHH's debt to equity ratio has increased from 27.1% to 36.6% over the past 5 years.
Debt Coverage: IHH's debt is well covered by operating cash flow (24.6%).
Interest Coverage: IHH is unprofitable, therefore interest payments are not well covered by earnings.
What is IHH Healthcare Berhad current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IHH's dividend (0.77%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.39%).
High Dividend: IHH's dividend (0.77%) is low compared to the top 25% of dividend payers in the MY market (4.3%).
Stability and Growth of Payments
Stable Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.
Growing Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: IHH is not paying a notable dividend for the MY market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IHH's dividend in 3 years as they are not forecast to pay a notable one for the MY market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kelvin Loh (46 yo)
Dr. Chi-Keon Loh, also known as Kelvin, serves as Managing Director and Chief Executive Officer of IHH Healthcare Berhad since January 1, 2020 and serves as its Executive Director since July 01, 2019. He h...
CEO Compensation Analysis
Compensation vs Market: Kelvin's total compensation ($USD2.46M) is above average for companies of similar size in the MY market ($USD581.17K).
Compensation vs Earnings: Insufficient data to compare Kelvin's compensation with company performance.
|MD, CEO & Executive Director||1yr||RM9.94m||no data|
|Group Chief Operating Officer||1yr||no data||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Group General Counsel & Company Secretary||no data||no data||no data|
|Group Chief Human Resources Officer||1.33yrs||no data||no data|
|Group Head of Internal Audit||7.83yrs||no data||no data|
|Group Head of Risk Management||2.17yrs||no data||no data|
|Group Head of Strategic Planning & Business Development (M&A) and CEO of South East Asia Ops. Div.||3yrs||no data||no data|
|Group Head of Business Transformation||0.67yr||no data||no data|
|Company Secretary||no data||no data||no data|
|President of IMU Health Sdn Bhd and C.E.O. & Vice-Chancellor of IMU Education Sdn Bhd||5yrs||no data||no data|
|Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S03||1.83yrs||no data||no data|
Experienced Management: IHH's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
|MD, CEO & Executive Director||1yr||RM9.94m||no data|
|Independent Non-Executive Director||6.33yrs||RM975.00k||no data|
|Independent Non Executive Chairman||3yrs||RM978.00k||no data|
|Independent Non-Executive Director||no data||no data||no data|
|Independent Non-Executive Director||no data||RM64.00k||no data|
|Non-Independent & Non-Executive Director||9yrs||RM9.29m||5.92% |
|Non-Independent & Non-Executive Director||1.17yrs||RM51.00k||no data|
|Independent Non Executive Director||2.75yrs||RM485.00k||no data|
|Independent Non-Executive Director||8.75yrs||RM1.14m||no data|
|Non-Independent & Non-Executive Director||1.83yrs||RM414.00k||no data|
|Non Independent Non Executive Director||0.75yr||no data||no data|
|Non-Independent & Non-Executive Director||no data||no data||no data|
Experienced Board: IHH's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources
- Name: IHH Healthcare Berhad
- Ticker: IHH
- Exchange: KLSE
- Founded: 2010
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: RM46.519b
- Shares outstanding: 8.78b
- Website: https://www.ihhhealthcare.com
Number of Employees
- IHH Healthcare Berhad
- Pantai Hospital Kuala Lumpur
- Level 11, Block A
- Kuala Lumpur
- Wilayah Persekutuan
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|IHH||KLSE (Bursa Malaysia)||Yes||Ordinary Shares||MY||MYR||Jul 2012|
|Q0F||SGX (Singapore Exchange)||Yes||Ordinary Shares||SG||SGD||Jul 2012|
|IHHH.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jul 2012|
IHH Healthcare Berhad, an investment holding company, provides healthcare services. It provides primary care services, such as treatment of basic illnesses, routine check-ups, and vaccinations. The company...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/22 11:16|
|End of Day Share Price||2021/01/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.